Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

The Beta Bionics iLet and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Beta Bionics (Nasdaq:BBNX) took to social media to announce the integration of its iLet Bionic Pancreas with Dexcom’s ...

SAN DIEGO – Dexcom has announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1. At initial ...

The CGM provides real-time glucose readings for 15.5 days. “As a disabled veteran living with Type 2 diabetes, becoming a grandfather has given me a powerful new reason to take charge of my health,” ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...

The G7 15 Day CGM in use. [Image courtesy of Dexcom] Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next month. The San ...

CISA has ordered U.S. government agencies to secure their systems within a week against another vulnerability in Fortinet's FortiWeb web application firewall, which was exploited in zero-day attacks.

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...

Fortinet has confirmed that it has silently patched a critical zero-day vulnerability in its FortiWeb web application firewall, which is now "massively exploited in the wild." The flaw was silently ...

Secretary of State Marco Rubio said no one raised the Caribbean military operation in closed-door meetings at a G7 summit. But ministers from France and the European Union publicly called them ...